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Staphylococcus aureus and Staphylococcus epidermidis are the leading etiologic agents
of implant-related infections. Biofilm formation is the main pathogenetic mechanism
leading to the chronicity and irreducibility of infections. The extracellular polymeric
substances of staphylococcal biofilms are the polysaccharide intercellular adhesin (PIA),
extracellular-DNA, proteins, and amyloid fibrils. PIA is a poly-β(1-6)-N-acetylglucosamine
(PNAG), partially deacetylated, positively charged, whose synthesis is mediated
by the icaADBC locus. DNA sequences homologous to ica locus are present
in many coagulase-negative staphylococcal species, among which S. lugdunensis,
however, produces a biofilm prevalently consisting of proteins. The product of
icaA is an N-acetylglucosaminyltransferase that synthetizes PIA oligomers from
UDP-N-acetylglucosamine. The product of icaD gives optimal efficiency to IcaA. The
product of icaC is involved in the externalization of the nascent polysaccharide. The
product of icaB is an N-deacetylase responsible for the partial deacetylation of PIA.
The expression of ica locus is affected by environmental conditions. In S. aureus and
S. epidermidis ica-independent alternative mechanisms of biofilm production have been
described. S. epidermidis and S. aureus undergo to a phase variation for the biofilm
production that has been ascribed, in turn, to the transposition of an insertion sequence
in the icaC gene or to the expansion/contraction of a tandem repeat naturally harbored
within icaC. A role is played by the quorum sensing system, which negatively regulates
biofilm formation, favoring the dispersal phase that disseminates bacteria to new infection
sites. Interfering with the QS system is a much debated strategy to combat biofilm-related
infections. In the search of vaccines against staphylococcal infections deacetylated PNAG
retained on the surface of S. aureus favors opsonophagocytosis and is a potential
candidate for immune-protection.
Keywords: Staphylococcus, biofilm, ica locus, Polysaccharide intercellular adhesin (PIA),
poly-β(1-6)-N-acetylglucosamine (PNAG), anti-PIA vaccine
INTRODUCTION
The recognition of “slime” as a mucilaginous material elaborated
by certain microrganisms such as molds and bacteria represents a
very early discovery in the history of microbiology. Impressively,
the first papers describing the ability of bacterial species to
form slime date back to the beginning of the 20th century. The
description of specific extracellular polymeric components that
structurally contribute to slime composition started with the sec-
ond half of the century, when Wilkinson (1958) and Catlin and
Cunningham (1958) began to report the existence of extracellular
polysaccharides and deoxyribonucleic acids.
The medical importance of bacterial biofilm was for the first
time enlighten by Bill Costerton, recognized as the “Father of
Biofilm,” who, in 1978 established an extraordinarily new micro-
biological paradigm, the “biofilm theory.” In an article, published
in Scientific American, he asserted that bacteria stick on avail-
able surfaces in glycocalyx-enclosed biofilms and that the ses-
sile bacterial population becomes predominant particularly in
medical ecosystems (Costerton et al., 1978). Costerton’s observa-
tions shifted the medical research from the attention to microbial
cell-wall structures, which are the interface of planktonic bacte-
ria with the environment, to the biofilm, which is the interface
of sessile bacteria with their environment (Costerton, 1989). The
introduction of the biofilm theory opened two lines of research:
the study of biochemistry and genetics of biofilms and their for-
mation and, on the other side, the improvement of the medical
diagnosis and treatment of biofilm-centered infections.
The profound influence that the Costerton’s insight exerted on
the bio-molecular knowledge of bacterial adhesion and on the
need of appropriate medical methods for diagnosis and treat-
ment of biofilm-related infections is analyzed in a review writ-
ten by one of us together with the Director of the Costerton’s
Institute. The review was thought in the sad circumstance of the
passing away of Bill, remembered as a charming Maestro for a
large number of colleagues and students (Ehrlich and Arciola,
2012).
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The early experimental works on slime producing bacteria
were just a prelude to the more elaborated concept of biofilm
(Mack et al., 1975; Costerton et al., 1978), where the sessile life-
cycle phase was progressively associated to the social behavior of
communicating and mutually interacting bacterial cells (Stoodley
et al., 2002), forming communities encased within a protective
extracellular matrix (Costerton et al., 1987) derived from the
elaboration of an exocellular slime (the glycocalix) (Gristina and
Costerton, 1984).
Over the years, progressive light was cast on the impor-
tance of glycocalix elaboration and biofilm formation not only
as a fundamental mechanism of adhesion and colonization of
biomaterial surfaces (Jacques et al., 1987), but also as a crit-
ical virulence mechanism enabling bacteria to escape the host
immune-response and resist medical antibiotic chemotherapies
(Gilbert et al., 1997; Costerton et al., 1999). The possibility for
bacteria with a planktonic phenotype, otherwise susceptible to
the host defenses and medical treatments, to switch to a sessile
form of life more adapt to survive to the aggressive environment
of host tissues, assumed a specific meaning in the pathogene-
sis of clinical infections, especially those associated to implant
materials.
The great difficulty to eradicate microbial infections gener-
ated by biofilm-forming bacteria in presence of implant materials
has received increasing attention over the last decades. Indeed,
once established on a biomaterial surface, biofilm-forming strains
are capable to resist and survive common antibiotic regimens
formulated against and active on planktonic bacteria.
Soon after the launch of the biofilm theory, Staphylococcus epi-
dermidis was early discovered to be one of the principal actors
of biomaterial-associated infections and, certainly, its ability to
colonize implant surfaces and produce resistant biofilms was
recognized as a key factor in determining its success.
With the studies on slime/biofilm production by clinical
strains, the biofilm was progressively demonstrated to be an
important mechanism in bacterial adherence and pathogene-
sis of infections associated to biomaterials surfaces (Christensen
et al., 1982). The production of biofilm was searched both by
phenotypic methods, such as the microtiter plate (MtP) test
(Christensen et al., 1985), the Congo red agar (CRA) plate
test (Freeman et al., 1989) and its optimization (Arciola et al.,
2002b), and by molecular detection of the ica locus, that had
been identified as the genetic basis of biofilm production in
S. epidermidis (Heilmann et al., 1996). The presence of ica
locus in S. epidermidis, detected together with the positivity of
phenotypic evidence of biofilm production, was then proposed
as a marker of virulence of S. epidermidis strains responsible
for implant-associated infections (Arciola et al., 2002a,b). PIA,
besides described in S. epidermidis strains (Mack et al., 1996), was
also described in S. aureus and the role of ica locus recognized
also in this species (Cramton et al., 1999). The ica locus was then
found widespread present in biofilm producing S. aureus strains
responsible for catheter and implant infections (Ammendolia
et al., 1999; Montanaro et al., 1999; Arciola et al., 2001).
The great attention that staphylococcal biofilms have received
in recent years is justified by the large prevalence of S. aureus
and S. epidermidis, but also of other emerging coagulase-negative
staphylococci, as etiological agents of implant-infections. For
instance, in orthopedics epidemiological studies have shown that
staphylococci are the primary cause of implant-infections, caus-
ing nearly 80% of all prosthetic infections (Arciola et al., 2005,
2014; Montanaro et al., 2011).
Bacteria in biofilms can resist antibiotics at concentrations up
to 1000 times higher than those active on the same bacteria in the
planktonic state (Ceri et al., 1999). Antibiotic substances target-
ing the biofilm phenotype are therefore urgently needed. In search
for the most efficacious antibiotic treatments active on biofilms,
it has become common to assay antibiotic substances not only
on planktonic bacteria to extrapolate minimal inhibitory con-
centrations (M.I.C.), but also screen them on sessile bacteria to
achieve relevant information on the minimum biofilm eradica-
tion concentration (M.B.E.C.) (Ceri et al., 1999; Parra-Ruiz et al.,
2010).
Apart from the efforts to identify the most active combina-
tions of conventional antibiotics to eradicate bacterial biofilms,
increased attention is being paid to identify new antibacterial
molecules specifically targeting the biofilm state and therefore
defined anti-biofilm substances. The great interest to counteract
biomaterial-associated infections caused by biofilm-producing
bacterial species has therefore seen the proliferation of stud-
ies screening different classes of compounds ranging from herb
extracts, natural antimicrobial peptides, molecules of microbial
origin to synthetic molecules. The intent has become not just
the treatment but also the prevention of biofilm formation.
This important goal can be achieved by the better knowledge
of the molecular mechanisms of biofilm production and con-
trol and by the development of anti-biofilm biomaterial surfaces
(Arciola et al., 2012; Campoccia et al., 2013). In this context,
the knowledge of biofilm pathophysiology plays a fundamental
role, as different strategies can be developed to contrast bacte-
rial colonization and biofilm formation. They all rely on a deep
understanding of the mechanisms implicated in biofilm produc-
tion and of the fine mechanisms that rule the expression of the
biofilm phenotype and govern biofilm formation. Twomain anti-
biofilm strategies are presently under consideration. One is based
on biofilm disaggregating agents, such as enzymes that attack
the PNAG (Dispersin B) or the extracellular DNA (DNase I) or
the biofilm proteins (proteinase k) (Arciola, 2009; Kaplan, 2009;
Arciola et al., 2012).
The other strategy is based on the modulation of the effector
molecules, an approach called quorum quenching (QQ), which
consists in interfering with the intercellular bacterial communi-
cations, with the aim at artificially inducing bacteria to assume
a planktonic rather than sessile phenotype. In other words, the
latter target consists in fooling the quorum sensing (QS) system.
Based on signal molecules often referred to as pheromones or
autoinducers, the QS system enables bacteria to sense their own
density in the milieu and modify their phenotype accordingly.
This involves ruling the expression of distinct traits for the specific
cellular phase of growth and/ormilieu colonization.
While some of the principal components of the QS system
in S. aureus and S. epidermidis have been unveiled, much still
remains to be elucidated as significant functional differences exist
between the two bacterial species and, even, among different
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strain types, which often happen to compete in the environ-
ment just using different allelic forms of the signal molecules.
These different alleles of signal molecules often exert the function
of QS interference in the competition among different types of
strains.
A brief description of some fundamental aspects of staphy-
lococcal biofilm pathophysiology concerning the ultrastructural
composition of the extracellular biofilm matrix, and the genetic
mechanisms governing biofilm formation will be depicted in the
next paragraphs.
CHEMISTRY OF PIA AND ALTERNATIVE FORMS OF BIOFILM
The investigation of the chemical nature of the extracellular
biofilmmatrix began rather early around the years ‘50 s. However,
in spite of many efforts made to elucidate its composition,
the difficult purification of bacterial extracellular matrix and
the multiplicity of analytical techniques adopted, often gener-
ating artifacts, initially led to divergent results. Thus, depend-
ing on their different experimental approach, different authors
described different main exopolysaccharide components: the
capsular polysaccharide-adhesin (PS/A) (Muller et al., 1993),
the polysaccharide intercellular adhesin (PIA) (Mack et al.,
1996), poly-β(1-6)-N-acetylglucosamine (PNAG) (Maira-Litrán
et al., 2002), and S. aureus exopolysaccharide (SAE) (Joyce
et al., 2003). In 2005, was finally demonstrated that PIA from
S. epidermidis was structurally identical to the poly-β(1-6)-N-
acetylglucosamine from the PS/A-overproducing strain S. aureus
MN8m (Sadovskaya et al., 2005), definitively solving a dilemma
lasted for more than a decade on the real chemical formula of
the main exopolysaccharide component of the biofilms of most
S. aureus and S. epidermidis clinical strains.
Currently, poly-β(1-6)-N-acetylglucosamine, alternatively
named with the synonymous terms PIA or PNAG, has therefore
been identified as the main exopolysaccharide component of
staphylococcal biofilm matrix. Interestingly, the same exo-
cellular polysaccharide has recently been identified even in
numerous other gram-negative bacterial species members of
the Proteobacteria family, including Escherichia coli, Yersinia
pestis, Pseudomonas fluorescens, Bordetella spp., Xenorhabdus
nematophila, Aggregatibacter actinomycetemcomitans, and
Actinobacillus pleuropneumoniae (Ganeshnarayan et al., 2009),
suggesting a convergent evolution in phylogenetically diverse
bacteria.
Although PIA certainly represents a main mechanism of
biofilm formation in S. aureus and S. epidermidis, numerous
advancements in the study of biofilm have shown the existence,
especially for S. aureus, of alternative forms of biofilm that are
PIA-independent. The observation that a minor proportion of
S. aureus strains can form biofilm even in the absence of the ica
locus and that certain strains carrying such locus continue any-
way to produce biofilm even after deletion of the locus suggested
the existence of ica-independent pathways (O’Gara, 2007). The
assumption of the possibility of alternative mechanisms to pro-
duce biofilms was long debated despites some very early studies
had already suggested the complexity of biofilm architecture and
the inclusion of extracellular polymeric substances different than
PIA, such as e-DNA and teichoic acids, in the biofilm matrix.
A number of proteins localized in the extracellular matrix of
biofilms have been identified that can generate PIA-independent
biofilms. The biofilm-associated protein (Bap), a 2276-amino
acid surface protein, is one of these proteins enabling biofilm
production even in the absence of production of the exopolysac-
charide component (Cucarella et al., 2004; Tormo et al., 2005).
The Bap protein seems to play a role prevalently in human staphy-
lococcal infections caused by coagulase-negative staphylococcal
(CoNS) species. The bap gene encoding for Bap has been iden-
tified in S. epidermidis, S. chromogenes, S. xylosus and a few other
CoNS species, where it is often carried in a putative composite
transposon (Cucarella et al., 2004; Tormo et al., 2005). However,
as far as S. aureus is concerned, the role of Bap seems less rele-
vant in isolates from human infections (Vautor et al., 2008; Tang
et al., 2013) and, up to now, exclusively strains of veterinary ori-
gin (e.g., bovine mastitis) have been found to harbor the bap gene
(Valle et al., 2012). However, the functions of Bap are still far from
being totally understood and are not limited to biofilm forma-
tion. Indeed, it has been found that Bap not only promotes the
adhesion, but also prevents the entry of S. aureus into epithelial
cells (Valle et al., 2012). Bap involvement in the pathogenesis of
infections is therefore more complex as this protein influences the
extent of bacterial internalization into host cells and consequently
tissue invasiveness.
In the production of biofilm more clinically significant is the
role of another protein factor, namely the accumulation associ-
ated protein (Aap). Among biofilm-forming S. epidermidis iso-
lates from total hip or total knee infected arthroplasties, up to
27% of the strains were found to be endowed with this surface
protein and negative to the ica locus (Rohde et al., 2007).
Differently, surface proteins such as SasG (Geoghegan et al.,
2010), SasC (Schroeder et al., 2009), Protein A (Merino et al.,
2009), and two fibronectin-binding proteins, namely FnBPA and
FnBPB (O’Neill et al., 2008), have been documented to contribute
to biofilm formation in S. aureus. Interestingly, S. aureus clinical
strains are all generally endowed with the ica locus. These alterna-
tive mechanisms of biofilm formation can probably concur and
could be switched on in different phases of the pathogenesis of
infections, adapting the characteristics of the biofilm extracellu-
lar matrix in response to external stimuli (Houston et al., 2011),
in order to colonize and establish the infection in host tissues,
while evading the immune response and the effects of antibiotic
treatments.
The protein components of staphylococcal biofilms are dis-
cussed in depth in a recent review that illustrates how a multitude
of proteins intervene at different stages of the biofilm formation,
with certain proteins contributing to the biofilm accumulation
and others mediating the primary attachment to the surfaces
(Speziale et al., 2014).
THE SYNTHESIS OF PIA
PIA, as described above, is now well-established to consist of
poly-β(1-6)-N-acetylglucosamine, a linear glucosaminylglycan
that plays a fundamental function in mediating intercellular
adhesion of bacterial cells. In addition to bacterial aggrega-
tion, this exopolysaccharide has important structural functions
in the biofilm matrix architecture, and is implicated in bacterial
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adhesion to biomaterial surfaces as well as evasion from host
immune-response (Vuong et al., 2004). PIA synthesis is medi-
ated by the icaADBC locus, first discovered and investigated by
Heilmann et al. (1996). The icaADBC locus was initially described
in S. epidermidis, but few years later its presence was confirmed
even in many other species of the Staphylococcus genus, S. aureus
included (Cramton et al., 1999). The ica locus is however part
of the “accessory genes” genome and not of the so-called “core”
genome, meaning that it is not found in all bacterial strains.
Its presence is exclusively observed as part of the virulon of
exopolysaccharide-based biofilm-forming staphylococcal strains.
In early studies, the ica locus was reported in a large proportion
of staphylococcal strains isolated from implant related-infections
(catheter-associated infections) (Arciola et al., 2001). Important
differences in the prevalence of ica-positive strains had previously
been observed also comparing clinical isolates (blood cultures)
with saprophytic strains (85% vs. 6%) (Ziebuhr et al., 1997).
Further evidence of the important role of PIA as a virulence
factor came also from experimental studies in rat models of
intravascular catheter-associated infections with isogenic mutant
strains deficient in PIA production (Rupp et al., 1999, 2001).
The icaADBC locus consists of four genes. The first two genes
of this gene cluster, respectively icaA and icaD, exert a pri-
mary role in the exopolysaccharide synthesis. The former gene
encodes for a transmembrane enzyme withN-acetylglucosaminyl
transferase activity, necessary for the synthesis of the poly-N-
acetylglucosamine polymer. However, the enzymic activity of
the product of icaA becomes significant and olygomers longer
than 20 residues are synthesized only when coexpressed with
the product of the icaD gene (Gerke et al., 1998). Conversely,
the product of the icaC gene appears to translocate the poly-N-
acetylglucosamine polymer to the bacterial cell surface, while the
icaB product operates the deacetylation of the molecule (Vuong
et al., 2004). Deacetylation of poly-N-acetylglucosamine polymer
is relevant for the structural development of exopolysaccharide-
based biofilm, enabling the fixation of the polymer to the outer
bacterial surface. The negative regulator termed intercellular
adhesin locus regulator (icaR) gene governs the expression of the
ica locus under the influence of SarA and the stress sigma σB
(Cerca et al., 2008).
While DNA-sequences homologous to the ica locus have been
identified also inmany staphylococcal species other than S. aureus
and S. epidermidis, up to now they have not been reported
for two staphylococcal species, respectively S. haemolyticus and
S. saprophyticus. Species such as S. lugdunensis, although endowed
with the ica locus, appear to produce a biofilm whose matrix
prevalently consists of protein material (Frank and Patel, 2007).
By CLSM and specific staining with fluorescent dyes we have
observed that the biofilm of S. lugdunensis is composed of both
PIA, which is stained with FITC-WGA, and proteins, stained with
Sypro®-Ruby, specific for the protein component (Figure 1).
PHASE VARIATION IN STAPHYLOCOCCI FOR THE BIOFILM
FORMATION
An interesting question is the phase variation of staphylococci,
which consists in a process of switching on/off for the expres-
sion/silencing of the ica locus, leading to a quantitative variation
of biofilm production. In S. epidermidis, the phase variation for
biofilm formation is thought to be a mechanism of persistence
and relapse. The insertion/excision of the insertion sequence
IS256 in the gene icaA or in icaB, or, more frequently, in icaC as
a possible mechanism of the phase variation was hypothesized by
Ziebuhr et al. (1999). These Authors observed the phase variation
in two S. epidermidis reference strains that had been subjected
to repeated in vitro subcultures. In a different way, the natural
occurrence of the IS256 insertion element either in ica locus or
in the genomic DNA of clinical strains of S. epidermidis - just as
they had been isolated, that is without artificial manipulations to
induce phase variations - was searched by Arciola et al. (2004).
The search for ica genes was carried out in 120 S. epidermidis iso-
lates from prosthesis-associated infections and in 4 S. epidermidis
reference strains and was compared with the bacterial phenotypes
(ability/inability to produce biofilm). Moreover, two biofilm-
negative RP62A-derived acriflavin mutants (D9 and HAM892)
were analyzed. The four genes of the ica locus appeared, in all
cases of that collection, strictly linked each other, so that they
were either all present or all absent, nor were detected gene dele-
tions within the ica locus. IS256 was present in eight out of
the 69 ica-negative strains and in 34 out of the 51 ica-positive
strains. However, when IS256 was found in the bacterial genomic
DNA, it was never found within the ica locus, this observation
suggesting that the insertion/excision of IS256 is not a natural
occurring mechanism for off/on switching the biofilm produc-
tion. In the same study, for the first time, two RP62A-derived
acriflavin mutants, D9 and HAM892, unable to produce biofilm,
were shown to harbor within their icaC genes, at the base 3319, a
1300-bp insertion corresponding to IS256. Although the insertion
was found within icaC, as in the study of Ziebuhr et al. (1999),
it was traced in a position rather different from that described by
Ziebuhr et al. (1999). The different point of insertion was ascribed
by the Authors to the different mutagenesis conditions, namely
repeated subcultures in the experiments reported by Ziebuhr
et al. (1999) and, instead, the chemical mutagenesis by acriflavin
in the study of Arciola et al. (2004). However, interestingly, in
none of the 120 S. epidermidis clinical isolates from prosthe-
sis associated infections the IS256 insertion element was found
within the ica operon, neither in some strains that, although ica-
positive, were biofilm non-producers. Thus, the insertion/excision
of IS256 in ica operon does not appear as a natural occur-
ring mechanism for switching off/on the biofilm production, but
rather as the consequence of either a chemical mutagenesis or
of manipulative mutations. Afterwards, in the same 2004 year,
only some months later, the phase variation of biofilm forma-
tion by an insertion sequence was described also in Staphylococcus
aureus by Kiem et al. (2004). A biofilm-negative phase-variant
S. aureus mutant was detected from six strains subjected to
repeated subcultures. Again, the icaC gene of the phase-variant
strain was found to be inactivated by the insertion sequence
IS256.
More recently, a mechanism of phase variation of the poly-N-
acetylglucosamine expression in Staphylococcus aureus has been
described that does not involve the insertion/excision of IS256 but
the expansion or contraction of a simple tetranucleotide tandem
repeat housed within icaC. Inactivation of IcaC by the expansion
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FIGURE 1 | Double stainingwithFITC-WheatGermAgglutinin (FITC-WGA,
for exopolysaccharide detection) and SYPRO Ruby (FilmTracer™ SYPRO®
Ruby BiofilmMatrix Stain, for protein detection) was carried out as
described in Ravaioli et al. (2012). (A) Green channel image showing PNAG
stainedwith FITC-WGA. (B)Redchannel image showing theproteic component
stained with SYPRO® Ruby. (C)Merged image of the two channels.
or contraction of this tetranucleotide tandem repeat results in
a PIA/PNAG-negative phenotype (Brooks and Jefferson, 2014).
And indeed, the expansion (or contraction) of a 4-nt tandem
“ttta” repeat shifts the reading frame of icaC and leads to a prema-
ture stop codon, truncating the IcaC protein at 303 amino acids,
47 amino acids shorter than the full-length protein. The Authors
suggest that, under certain conditions, the loss of PIA/PNAG pro-
duction may be advantageous during infection. Inactivation of
icaC is therefore a mechanism of phase variation for PIA/PNAG
expression and icaADB may contribute to the bacterial fitness, by
a mechanism still unknown and involving the absence of an intact
icaC gene and of PIA/PNAG production. All these findings indi-
cate that the mutation of icaC is the preferred “off switch” for
PIA/PNAG production.
GENETIC CONTROL OF BIOFILM METABOLISM
The numerous studies on the genetic control of biofilm pro-
duction in staphylococci have led to consider the expression of
the biofilm forming phenotype very complex. This complex-
ity is in part because there is a multiplicity of factors con-
tributing to the biofilm extracellular matrix, these varying with
the bacterial species but also, within the same species, with
the strain type. In addition, biofilm production derives from
a complicated equilibrium of production of extracellular poly-
meric substances, including amyloid fibrils and polymerized
phenol soluble modulins (PSMs), and their catabolism deter-
mined by expression of enzymes such proteases, nucleases and
soluble, still non-polymerized, PSM peptides (Schwartz et al.,
2012).
A fine control of sessile and planktonic phenotypes is highly
required to explicate a well coordinate and efficacious action dur-
ing the invasive phase. The expression of biofilm is therefore
governed by mechanisms of collective coordination. These mech-
anisms enable not only the sensing of environmental stimuli, but
also the density of bacterial cells belonging to the same group and
sharing the same pheromone system.
Diverse studies have documented as ica-positive S. epidermidis
easily express their biofilm-forming phenotype under in vitro
conditions. Differently, in S. aureus, whose strains are generally
all endowed with ica locus, the biofilm production is not always
fully expressed in vitro and often requires a modified atmosphere
(anaerobiosis) or supplementation of the growth broth with
nutrients in order to be fully manifested (Arciola et al., 2001;
Cramton et al., 2001; Stepanovic´ et al., 2003, 2007).
Vice versa, S. aureus strains manifestly express increased
biofilm production in vivo (Ammendolia et al., 1999; O’Gara,
2007). In vitro stress conditions induced by iron limitation, star-
vation, thermal stress or subinhibitory concentrations of ethanol,
salt and some antibiotics have also been found to increase the
amount of biofilm produced.
Therefore, a series of stimuli from the environment and from
bacterial density are sensed by bacterial cells and influence the
expression of biofilm-forming phenotype. As far as the response
to environmental stimuli is concerned, important regulators of
staphylococcal biofilm production are represented by the two-
component signal transduction systems (TCSs) and σB. TCSs
mediate a diverse range of adaptive responses in response to envi-
ronmental stresses. First identified in S. aureus (Fournier and
Hooper, 2000), the presence of ArlRS TCS was later confirmed
also in S. epidermidis (Zhu et al., 2010). Recent data show that
ArlRS plays an important role in the regulation of S. epidermidis
biofilm formation, and acts in an ica-dependent manner distinct
from the role of ArlRS in S. aureus biofilm formation, which was
found to be ica-independent (Wu et al., 2012). In addition to
influencing biofilm formation, ArlRS is also involved in the mod-
ulation of bacterial autolysis and, consequently, of e-DNA release
contributing to the biofilm extracellular matrix.
In S. aureus another two-component regulatory system is the
lytSR operon that affects murein hydrolase activity and autolysis
(Brunskill et al., 1996). The LytS sensor component, interacting
with its cognate response regulator LytR, activates the transcrip-
tion of genes under its control. The target of the system is the
lrg/cid operon, which has been shown to be a regulator in the
control of cell death and lysis during biofilm development (Rice
et al., 2003; Rice and Bayles, 2008). The cidA gene encodes a
putative holin protein that is an effector of murein hydrolase
activity and cell lysis, while lrgA encodes a putative antiholin that
is an inhibitor of these processes (Rice et al., 2007), Thus, the
biological function of the cid and lrg operons is to provide a
source of extracellular genomic DNA (eDNA) for interweaving
and strengthening with this molecule the scaffold of the matrix of
biofilm.
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The complex intervening factor influencing biofilm
production and, in particular PIA synthesis, are depicted in
Figure 2.
It has been earlier anticipated that biofilm is also influenced by
bacterial density. Intercellular communication in staphylococci is
enabled by the so-called quorum sensing (QS) systems.
The role of QS system in controlling staphylococcal biofilm
dispersal and structuring is presented in details in another review
of this series (Le et al., 2014) and will be treated here only
summarily.
In staphylococci, the system that regulates the expression of
virulence factors in response to cell density is the accessory gene
regulator (agr) system (Recsei et al., 1986; Novick et al., 1993).
The importance of the agr in biofilm formation in both S. aureus
and S. epidermidis was first shown by the group of Michael Otto
(Otto, 2001), who highlighted that, while agr leads to increase
expression of toxins, serine protease, DNase, fibrinolysin, entero-
toxin B, and toxic shock syndrome toxin-1, it decreases the
expression of colonization factors and biofilm formation. Since
biofilm is one of the most important virulence factors in chronic
bacterial infections, the use of agr-inhibiting substances for anti-
staphylococcal treatment has been proposed, but it may have
severe drawbacks, as it might turn an acute into a chronic infec-
tion by promoting the expression of colonization factors (Otto,
2001).
Among the peptides strictly controlled by the agr locus, a fam-
ily of short staphylococcal peptides, Phenol-Soluble Modulins
(PSMs), characterized by amphipathic a-helical structure confer-
ring surfactant-like properties, have been shown to be key effector
molecules in biofilm structuring, dispersal and dissemination, by
a mechanism consisting in the disruption of non-covalent inter-
actions between biofilm matrix macromolecules (Otto, 2013).
These peptides have been demonstrated to be relevant in the
pathogenesis of S. aureus and S. epidermidis biofilm-associated
infection, under both in vitro and in vivomodels (Le et al., 2014).
THE DEBATED PROMISE OF QUORUM QUENCHING (QQ)
In the introduction, quorum quenching (QQ), alternatively
known as quorum interference, has been mentioned as one of the
latest strategies to counteract staphylococcal infections. In nature,
QQ is a strategy pursued by antagonistic bacterial strains com-
peting for the environment (Geisinger et al., 2009). QQ can be
achieved by alternative tactics, these including quorum sensing
disruption through inhibition of signal molecule biosynthesis,
signal molecule inactivation and blockade of signal transduction
(Kiran et al., 2008; Rampioni et al., 2014). A weakness of the QQ
approach resides in the fact that not only QS systems markedly
differ between Gram-positive and Gram-negative bacteria, but
also their functions are different in the same genus and some-
times even in diverse strain types of the same species (Geisinger
FIGURE 2 | Scheme of the complex network of interactions governing
biofilm formation and disruption in S. aureus based on current scientific
evidences. The right side of the figure illustrates the anabolic phase of biofilm
with the production of some fundamental extracellular polymeric substances
(EPS) such as PIA, extracellular-DNA (eDNA) and amyloid fibrils. The lytSR
operon with its target genes lrg/cid, which affects murein hydrolase activity, is
also represented. The center of the figure reports the protein membrane
components implicated in biofilm formation, these including the FnBPs
adhesins, the Biofilm associated protein (Bap), SasG and Spa. Conversely, in
the left side of the figure, the molecules playing a role in biofilm catabolism
and extracellular biofilm matrix disruption, such as phenol-soluble modulins
(PSMs) and extracellular proteins, are reported. Agr QS system, σB factor and
SarA appear to act as central regulators, orchestrating the bacterial behavior in
response to stress factors, cellular densities and cell cycle phases.
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et al., 2012). This means that it may result hard to find universal
key molecules able to exert their desired action on all pathogens
and that what can inhibit biofilm-formation in a species could
stimulate it in another.
However, while inhibiting agrwould be counterproductive and
the use of QS inhibitors is debatable for combatting biofilm-
associated infections by staphylococci, vice versa, QS interference
is expected to become a powerful strategy to control virulence and
antibiotic tolerance of Gram-negative bacteria.
To date, methods that can be used to disrupt quorum sensing
include: (1) antagonizing signal binding to LuxR-family receptor,
(2) inhibiting signal production, (3) degrading signals, (4) trap-
ping signals, and (5) suppressing synthase and receptor activities,
stabilities or productions (Hirakawa and Tomita, 2013).
Overall QQ appears an important strategy for applications in
medicine (but also veterinary and agriculture), opening new hori-
zons for preventive/therapeutic measures alternative or adjuvant
to conventional antibiotics (Costerton et al., 2007).
PIA IN IMMUNOTHERAPEUTIC STRATEGIES TO COMBAT
STAPHYLOCOCCAL INFECTIONS
The poly-N-acetyl-β-(1,6)-glucosamine, PNAG, also designed
as PIA, is a high-profile candidate for a vaccine that could
possibly provide protection against both coagulase-positive and
coagulase-negative staphylococci. As outlined above, the native
form of PIA/PNAG is partially de-N-acetylated (dPNAG). It has
been observed that only antibodies to the deacetylated epitopes
of PNAG are able to give protection, favoring opsonization of
S. aureus and killing by human neutrophils (Kelly-Quintos et al.,
2005, 2006).
Antibodies that bind to PNAGwith either low (<15%) or high
(>90%) levels of acetate were shown to have a superior opsonic
and protective activity than antibodies that bind to PNAG with
only high levels (>70%) of acetate (Cerca et al., 2007). Both in
S. epidermidis and in S. aureus, IcaB is a deacetylase that causes
partial deacetylation of PNAG and thus ensures a better surface
retention of PNAG and optimal biofilm formation.
By studying the acetylation of PNAG by icaB negative S. aureus
mutants, Cerca et al. (2007) observed that less PNAG was asso-
ciated to the bacterial surface, and this strain was highly suscep-
tible to antibody-independent killing by neutrophils. A S. aureus
mutant with over-expression of icaB producing primarily surface-
associated PNAG, was more susceptible to opsonophagocytosis
with antibody to deacetylated PNAG. The higher retention of
deacetylated PNAG on the surface of S. aureus provides a molec-
ular mechanism explaining the superior opsonic and protective
activity of antibody to dPNAG (Cerca et al., 2007).
While there is a large consensus on the need of a vaccine pro-
tecting people from staphylococcal infections, there is much less
clarity about the choice of efficacious candidates for a component
vaccine. Projan et al., in discussing the possible targets of an anti-
Staphylococcus vaccine, list almost eight diseases and about thirty
possible molecular targets (Projan et al., 2006).
The choice of an appropriate antigen for immunotherapy
should attentively consider the issue of the immune evasion. In
fact, PIA/PNAG, in addition to its role in intercellular adhesion
and biofilm formation, has been pointed out to play a role just
in the immune evasion by bacteria. Evidence suggests that anti-
bodies against PIA/PNAG often recognize the secreted PIA/PNAG
rather than its surface-associated form, this behavior resulting in
an ineffective immune response (Cerca et al., 2007). An effective
immune response against surface-associated PIA/PNAG has been
evoked by a conjugate vaccine, composed of the Staphylococcus
aureus PNAG and Clumping Factor A, which has been proved
successful in eradicating infection (Maira-Litrán et al., 2012).
Thus, PIA/PNAG protects the bacteria from immune defenses
but, otherwise, it could actually be the target of an effective
immune response.
Although this field is rich of interests and researches, and
progress have been made, further experimental, epidemiological,
pre-clinical and clinical studies are required before an efficacious
vaccine could be achieved.
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